SOHM Inc (PK) (SHMN) Quote

It’s gonna take something very substantial to get this moving.
Not sure what it will be, tweets alone won’t do it.

If they ever get the gummies out on the market (and with SHMN's track record, that's a big IF), what do you think they will cost? When SHMN had their toe fungus for sale, it was about 4x the market value of others. There is alot of competition in the gummy market on Amazon. From their twitter post, the gummies are in a 60 ct bottle.

Here is a 60 ct of Amazon Essential Melatonin gummies that go for less than 10 dollars with free shipping.

Amazon Essentials Melatonin Gummies

Think SHMN can beat that?

SHMN talking about ABBIE sounds like a chiropractor that claims they can cure cancer by cracking your neck.....


SOHM, Inc.
@sohminc
·
19m
ABBIE is set to reshape crop development worldwide - promising heat-resistant plants and sustainable farming solutions.

imo, others may disagree, the pps won't make any sustained move until a License deal is made, or Kits are sold. Those that invest in sub pennies aren't the same crowd that attends AACR, and the crowd that actually " invests " in sub pennies is small.

Those players want to see concrete proof that ABBIE is for real, will add millions in rev and really boost the profit line.

The other crowd that looks for runners to flip stays away from here due to lack of liquidity.They would rather play a diluting pig that at least gives them an opportunity to time a co dump or 10.

This is all so obvious to anyone who trades down here...

jmo

need Atty Letter by 4/29.....

Speaking for myself (tho others may agree), this is one of those days where the Company needs to step up and (Hobby Lobby decision aside) do what is needed to at least sustain PPS and maintain or improve shareholder value.

One week after a presentation that *should* have marked a sea change in PPS, prices and volumes remain flat enough that a single trade worth $37.50 shortly after noon today caused an erosion of over $250,000 in market cap by close.

You cannot blame this on nefarious action - even our resident IHub basher. There is no reason (outside of the Company's failure to engage in serious public outreach) for this Company to close with only a couple of hundred dollars in trades (if that) during the course of a day. I've reached out to several people I know over the last few months, many of whom have thrown a few bucks in, but iHub members should not have to serve as the Company's IR department.

The Company must do more to engage potential investors. Period.

Tweet/Link to article on Linkedin: Discover the 9 trends changing the future of medicine and transforming pharmaceuticals 

Check out: https://t.co/yxIsQnKs5S $SHMN #PharmacyTrends #MedicineTrends pic.twitter.com/J1bVfl6NbA— SOHM, Inc. (@sohminc) April 15, 2024

https://www.linkedin.com/pulse/9-pharmaceutical-treatment-trends-shaping-future-whats-next-xtqcc/?trackingId=lJfQR8ALRUCDTnOGr64QPA%3D%3D

hL shmn

Lots of good technical information in this post.

Thank you. hL shmn

$SHMN: MPSTOCK: It's NOT your fault. Mktg needs to do a better job.
URGENCY is IMPORTANT.

>>I just don’t see a catalyst right now that will move the price up
1. The CATALYSTS have been clearly communicated 👇️
The company is actively exploring, negotiating, and collaborating with several Japanese companies to expand its business.

This expansion includes the utilization of gene-editing technology called ABBIE, as well as licensing opportunities.

The management remains committed to…— SOHM, Inc. (@sohminc) March 19, 2024

And we're EXPECTING developments [not just updates in a few weeks]; ABBIE results have been
presented at AACR24, peer reviewed pubs.

2. This is NOT some '10' yr old tech [as some '10' yr. old brain stated].The person is CLUELESS about
the SINGLE most IMPORTANT thing for Gene-Editing [Plant /Human use], i.e., Off-Target Limitations & unwanted mutations resulting in cancer etc.
Can't use ChatGPT & think they know everything! It's an Experiential acquisition.
Moreover, '10' yr. Old tech in Gene-Editing is ONLY now coming to fruition, via FDA approvals.
The ONE thing that can't be done is to predict Success/Failure, by how some company sold off ABBIE, B/C they
were sure it won't work! It takes Several Hundred $Millions to find out how & why it would work, in one area vs others.
TIME, $ & Statistics are key,NOT some dumb-A** opinion, about "10" yr old tech.
That's the most dumbest thing I've heard here!
We're talking about Permutations & Combinations in the 10's of Millions! And that's why there is a PROTOCOL for DESIGN, TESTING & V&V
And what's good in one area, may fail in another area [case in point, Genentech's AVASTIN, failed as a breast cancer drug, but is a major success in
many other therapies...making > $5B for Roche every year! This is just ONE Drug!

**********************************************************************************************************
ABBIE is resolving off-target edits by using the latest advances in:
-- Enzymes,
-- Guide RNA and
-- Cell or tissue-specific delivery.

ABBIE is able to significantly improve gene-editing precision with improved systems for DNA insertion.
ABBIE’s cell engineering tools and systems can reduce incidences of off-target edits by:
-- not inducing double-stranded breaks
**********************************************************************************************************

Looking more and more like I was right when I said we will be still in this price range towards the end of 2024
I just don’t see a catalyst right now that will move the price up.
Collaboration with other businesses or who ever will not cut it.

Paid basher? Lolololol

I bet you believe in market signals like 911 too.

The Easter Bunny?

I said show me...not talk for others...and this I already know, resident paid bashers rarely ever leave...

I'm here to stay.

LMAO !

Coastar Therapeutics is a start up that got some initial seed money from an investor. I wonder what value they add to SHMN or are they looking to get some investment cash from SHMN.

Phase 1 was announced over a year ago, topicals, the easiest thing to manufacture. I wonder what year that will be completed. Phase 2 and 3 might be done in our lifetime....

You know exactly what i'm talking about. So do members of this board. If anyone doubts it, say something he doesn't like then prepare for nasty messages and negative posts on any stock you post on.

Like I said, classic board bully.

I'm here to stay.

what stocks do I bash, show me....

and numerous times you have no idea what your talking about....funny you always fail to mention this, like it doesn't exist.

https://www.globenewswire.com/news-release/2023/10/10/2757629/0/en/SOHM-Collaborates-with-University-of-Arizona-Center-for-Innovation-to-Advance-ABBIE-a-Groundbreaking-Non-Viral-Gene-Editing-Technology.html

And you have no idea how Dr Auguilar retained ABBIE from Kiromic along with all the problems the CEO was having at the time....as I told you before, contact Kiromic and inquire.

And another thing you fail to mention is how far this science has come since then and where it's going.

some entertainment when you were in a flip...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173053796

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172992391

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173031956

I've said it numerous times, ABBIE is 8-10 year old tech. It's gone through a few companies before and no one went with it. There's a reason it landed with a OTC Pink Sheet company like SHMN.

$SHMN: I can't repeat this ENOUGH...

Company needs to up the Marketing Ante on their peer reviewed results..
Genentech spent ~3Billion on AVASTIN [one of the use cases was for Wet AMD].
They also got sued B/C AVASTIN performed horribly in breast cancer for women.

All of the above was W/O the ability nor benefit of gene-Editing nor feedback from reading back edited DNA via NextGEN Seq.

There are companies out there that will THROW $100's of Millions, now that CRISPR is FDA approved.
No more MoUs & LOIs etc...ask for Investment & Committed POs.
Have a Good Weekend.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174227148

The "big reveal" really has the investors in a frenzy. 0 volume in 2 days.

Well since you bash stocks, this applies to you as well.

[Myth

04/08/24 5:11 PM

Post #65420 on SOHM Inc (SHMN)

nothing good about mindless bashers....

]

sure seems like you do...

I couldn't care less about what you think

it's not curious at all that those that bash stocks end up getting their stocks bashed.....

funny how they don't like it...

I couldn't care less about what you think, much less explaining anything to you.

so tell me, why is SHMN the only stock you bash ?

$SHMN: HL: Anyone with access to SoHM...Please pass this on to Aguilar & Gallegos...ASAP

1. Electroporation alters Phenotypes & also does NOT offer the highest yields to
a. Cell Health
b. Maximizing Payload ["Viral Vector"]
c. Efficiency & Yield of Payload Delivery

Have you looked at cutting edge alternatives to Electroporation? Why constrain yourself to Old-Tech?
Maybe get a FREE TRIAL [for data generation from👇️]
https://www.cellfebiotech.com/how-it-works/
I have NO affiliation to 👆️
2. If you're using a FACS type cell sorter [per your poster] for CD34, then you would be prone to a certain % of error due to
Phenotype changes.

If you need to know who I am...we'll talk thro' Julio M Clark.

And Pls...F*ing publish a Hi-RES POSTER of what you presented at AACR! WTF is Barron trying to hide here!
WTF is your mkt-ing dept doing? Twiddling thumbs?

Board bullies hate when they can't follow you to another board to trash your stocks. They also hate when they can't send you nasty messages.

It's curious that the person that hates bashers so much has no issues bashing other stocks of people that disagree with them. That post history works both ways...

Masters? Good God, put the kool aid down.

LOL !

Then post nonsense that notifies me and brings me to the board....

yeah, it has nothing to do with your masters orders, along with the vendetta you have against this co...

with all the stinkers that were pumped by you over the years that are now worthless, SHMN is the one you just happened to fixate on....yeah, that's it....

so tell me, why is SHMN the only stock you bash ?

What's funny is living rent free in your head.... LOL

"Why are you here?" Then post nonsense that notifies me and brings me to the board....

so something is funny that you have no idea of what you are laughing at ?

par for the course....

Hopefully attending DCAT proves beneficial to the co as well.....

Maybe they received some questions about the Tweet yesterday, just a guess....I hadn't seen the Tweet from yesterday...

I suspect that most contributors to this board have a good sense of what was covered during the preso; I'm hoping that they can capitalize on the momentum from AACR and share it with a broader audience.

New tweet, I don't why it was tweeted today PR is from April 1

We're teaming up with Coastar Therapeutics to transform the way we edit genes using carriers from red blood cell membranes.

Click through to the press release: https://t.co/w6DjjgehJy#Biotech #GenomeEditing $SHMN #SOHMPress pic.twitter.com/mEgPCVo46I— SOHM, Inc. (@sohminc) April 12, 2024

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

https://www.nasdaq.com/press-release/sohm-inc.-and-coastar-therapeutics-sign-mou-and-announce-collaboration-to

Maybe I'm just assuming, but I think I know what they presented, not sure what more they could say. They didn't say how it was received ? This Tweet satisfied me, but further discussion would be welcomed. They hinted it was coming....

SOHM, Inc.
@sohminc
We’re thrilled to announce that our presentation at #AACR was met with an exceptional reception. It was an honor to showcase our technology to esteemed researchers and leaders in the biotech industry.

The overwhelming interest and impact generated by our innovation have been truly remarkable.

Stay tuned for more updates following the conclusion of the conference.

$SHMN

According to this statement, things went very well, I guess we will find out in coming weeks/ months.

The overwhelming interest and impact generated by our innovation have been truly remarkable.

Regardless, they chose SHMN to establish a distributive presence in the US. What's in it for Sohm remains to be seen.

The other one has a track record of being an exec in afore mentioned Co's in CA.

LOL Sure... That's believable....

$SHMN: MDP: One of us seems to have SUCCESSFULLY convinced ourselves that he/She is a EXPERT at DNA Science, FDA, Pharma Cos ....etc ..

The other one has a track record of being an exec in afore mentioned Co's in CA.

I totally agree that they'd be screaming about a signed deal (as well they should).

I'm looking for that middle ground between announcing a signed deal and meaningless pump. They've announced that they were presenting, but then didn't discuss what they presented, how it was received, or put it into terms of how it may benefit the company.

I'd love to see them use this as an opportunity to describe what they spoke about (without getting too far into the weeds) to create perceived value around ABBIE without resorting to pumpy "there's an LOI to investigate the possibility of a partnership at some point in the future" type stuff. Call it a substantive pump, if you will.

With a fully reporting company, a PR is just that - an announcement to the press about *something*. It need not have direct revenue implications, or specifics. It's generally just fluffy good news.
With a non-reporting company, it has to do double duty - announce disclosure that would normally go into an 8-k, but also do the good news reporting.

While most pinks swing waaaaaay too far toward the fluff end of the spectrum and dive into pumpy bullshit, I think SHMN would benefit from sharing a bit more good news (albeit substantive good news).

Well, you successfully misunderstood everything that I posted. Good job.

$SHMN:MDP: You're running too many ASSUMPTIONS... just pure B.S & guessing!
1. Stallion Labs chose $SHMN as their SOLE distributor in N.America (that's a huge mkt)
2. Vol & Vol discounts are a Non-Issue. You need to check out the company (Stallion Labs). They'll provide both,
3. Medical Facility? $SHMN PR'd in Dec '23 that they've been REGISTERED with the U.S. FDA as both mfg & distribution facility.
So it's a NON-ISSUE!

The issues that I (&others) have are:-
1. Need Ms. Jacob to be Pro-Active & get the website updated, as a real co. with RESEARCH FACILITIES!
I believe that's ONE of her core responsibilities
2. Barron & Tony need to update S/Hs on sales & mkt initiatives. I believe Tony's core responsibility is sales (subset of Finance)
3. As was obvious Dr. Aguilar & Gallegos have been grinding away. Thank you to both! And Aguilar...looks to be working on the mkt too!

We're past the '90' day review period. So it's TIME to REVIEW PERFORMANCE!
This is NOT the FEDERAL GOVT!

Stallion Labs has a presence in the US for any of their products since 2009? That's news to Stallion Labs....

They really picked a powerhouse marketing machine in SHMN. Can't even get a website up or keep their self touted Amazon store open...

https://www.stallionlabs.com/international-presence.php

I think your confusing the crap you used to pump that are all worthless now to a much better company with a product that is real....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173031956

bash all you want, no one is buying it...

If Stallion Labs was already selling their product direct in the US to customers, why do they need SHMN? They wouldn't.

No "real" investors are going to touch a alternative reporting OTC stock without audited financials.

SHMN lives in the OTC, they only will get flippers and traders down here.

you really are an expert...lol....

Stallion labs has been manufacturing Levetiracetam since 2009. In 15 years they should already have a large market share.

It is my understanding SHMN now has the exclusive rights to distribute the Stallion brand of the drug to the share of the market Stallion has already established. I also believe that if Stallion thought SHMN didn't have the distribution capabilities they wouldn't have struck an exclusive deal with them to do so.

You don't think that if anything came from it that amounts to a signed deal it would be PR'd and shouted from the roof tops ?

imo Seeking Alpha type pumps can work, they could bring in more flippers, what I want to see is actual investors....

With the PR's we already had, along with engaging IBN to spread the word, and X, it isn't working, that's for sure.

The company has retained Investor Business Network (IBN) for its public relations activities, and our basic corporate profile is live throughout its network. Here are a few links:

InvestorBrandNetwork (https://t.co/0ffht9X0ph)
NetworkNewsWire (https://t.co/Oar1lUxkQq)
BioMedWire…— SOHM, Inc. (@sohminc) August 28, 2023

frustrating for sure, seems to me they need a signed License deal, or kits, to bring the disbelievers off the fence, jmo....

good talk JD...